Ensuring Compliance Against Drug Diversion Act of 2020
Latest action · Nov 18, 2020 Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedOct 23, 2019
- Passed HouseNov 17, 2020
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Ensuring Compliance Against Drug Diversion Act of 2020
This bill provides statutory authority for certain regulations governing the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances.
It terminates the registration of individuals and entities when they die, cease legal existence, discontinue business, or surrender such registration. It sets forth notification requirements, as well as conditions for transferring or assigning a registration.
Cosponsors 1
Members who signed on, in the order they did. All signed on Oct 28, 2019.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-OR | Greg Walden | Oct 28, 2019 |
Committees 3
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Oct 23, 2019Markup Sep 9, 2020Reported Nov 17, 2020 |
| Health Subcommittee | Referred Oct 26, 2019 | |
| House | Judiciary Committee | Referred Oct 23, 2019Discharged Nov 17, 2020 |
| Crime and Federal Government Surveillance Subcommittee | Referred Nov 15, 2019 | |
| Senate | Judiciary Committee | Referred Nov 18, 2020 |
Actions 15
Everything that happened, newest first.
- Nov 18, 2020Received in the Senate and Read twice and referred to the Committee on the Judiciary.
- Nov 17, 2020Mr. Pallone moved to suspend the rules and pass the bill, as amended.
- Nov 17, 2020Considered under suspension of the rules. (consideration: CR H5819-5820)
- Nov 17, 2020DEBATE - The House proceeded with forty minutes of debate on H.R. 4812.
- Nov 17, 2020Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5819)
- Nov 17, 2020Motion to reconsider laid on the table Agreed to without objection.
- Nov 16, 2020Reported by the Committee on Energy and Commerce. H. Rept. 116-584, Part I.
- Nov 16, 2020Committee on the Judiciary discharged.
- Nov 16, 2020Placed on the Union Calendar, Calendar No. 482.
- Sep 9, 2020Committee Consideration and Mark-up Session Held.
- Sep 9, 2020Ordered to be Reported by Voice Vote.
- Nov 15, 2019Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
- Oct 26, 2019Referred to the Subcommittee on Health.
- Oct 23, 2019Introduced in House
- Oct 23, 2019Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Debate and remarks H5819, H5820Text printed H5819Notices H5865Estimated budget effects of H.R. 4812, Ensuring Compliance Against Drug Diversion Act | Frank Pallone, Jr. D-NJ, Greg Walden R-OR, H. Morgan Griffith R-VA, John A. Yarmuth D-KY | Nov 17, 2020 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Committee report
Congressional Budget Office cost estimate
- Nov 13, 2020H.R. 4812, the Ensuring Compliance Against Drug Diversion Act of 2019As ordered reported by the House Committee on Energy and Commerce on September 9, 2020
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 168, October 23, 2019, page H8458.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 116-106 | COMBATING AN EPIDEMIC: LEGISLATION TO HELP PATIENTS WITH SUBSTANCE USE DIS- SORDERS356 pages | Energy and Commerce Committee | Mar 3, 2020 |
Titles 5
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Controlled Substances Act to provide for the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances or list I chemicals, and for other purposes.
- Short Title(s) as Introduced
- Ensuring Compliance Against Drug Diversion Act of 2019
- Short Title(s) as Reported to House
- Ensuring Compliance Against Drug Diversion Act of 2019
- Short Title(s) as Passed House
- Ensuring Compliance Against Drug Diversion Act of 2020
- Short Titles from RFS (Referred to Senate) bill text
- Ensuring Compliance Against Drug Diversion Act of 2020
Subjects
Assigned by the Library of Congress. Policy area: Crime and Law Enforcement.
Text 4
Each version as it was printed, newest first.
- Nov 18, 2020Referred in Senate
- Nov 17, 2020Engrossed in House
- Nov 16, 2020Reported in House
- Oct 23, 2019Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
